NF-κB is constitutively active in MTC through the RET-induced phosphorylation, ubiquitination, and proteosomal degradation of inhibitors of NF-κB (IkB), which allows NF-κB to enter the nucleus and bind to DNA [65]. The gene discussed is NFKB1; the disease is medullary thyroid gland carcinoma.